Literature DB >> 11154068

Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells.

J Plendl1, C Snyman, S Naidoo, S Sawant, R Mahabeer, K D Bhoola.   

Abstract

Angiogenesis is the sprouting of new capillary blood vessels from pre-existing ones. The kinin family of vasoactive peptides, formed by the serine protease tissue kallikrein from its endogenous multifunctional protein substrate kininogen, is believed to regulate the angiogenic process. The aim of this study was to determine the expression of tissue kallikrein and kinin receptors in an in vitro model of angiogenesis. Microvascular endothelial cells from the bovine mature and regressing corpus luteum were used only if they reacted with known endothelial cell markers. At first the cultured endothelial cells began sprouting, and within four weeks formed three-dimensional, capillary-like structures. Immunolabelling for tissue prokallikrein and the mature enzyme was intense in the angiogenic endothelial cells derived from mature corpora lutea. Immunoreactivity was lower in non-angiogenic endothelial cells and least in angiogenic endothelial cultures of the regressing corpus luteum. Additionally, using specific antisense DIG-labelled probes, tissue kallikrein mRNA was demonstrated in cells of the angiogenic phenotype. Immunolabelled kinin B2 receptors, but not kinin B1 receptors, were visualised on angiogenic endothelial cells. Our results suggest an important regulatory role for kinins in the multiple steps of the angiogenic cascade that may occur in wound healing and cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154068     DOI: 10.1515/BC.2000.135

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  6 in total

1.  Bauhinia bauhinioides cruzipain inhibitor reduces endothelial proliferation and induces an increase of the intracellular Ca2+ concentration.

Authors:  Mehmet Bilgin; Christiane Neuhof; Oliver Doerr; Utz Benscheid; Sheila S Andrade; Astrid Most; Yaser Abdallah; Mariana Parahuleva; Dursun Guenduez; Maria L Oliva; Ali Erdogan
Journal:  J Physiol Biochem       Date:  2010-08-02       Impact factor: 4.158

2.  Crystallization and preliminary crystallographic studies of human kallikrein 7, a serine protease of the multigene kallikrein family.

Authors:  Israel S Fernández; Ludger Ständker; Wolf Georg Forssmann; Guillermo Giménez-Gallego; Antonio Romero
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-07

3.  A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness.

Authors:  W C Wolf; D M Evans; L Chao; J Chao
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.

Authors:  A Del Rosso; O Distler; A F Milia; C Emanueli; L Ibba-Manneschi; S Guiducci; M L Conforti; S Generini; A Pignone; S Gay; P Madeddu; M Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

5.  Tissue kallikrein and kinin receptor expression in an angiogenic co-culture neuroblastoma model.

Authors:  S Naidoo; D M Raidoo
Journal:  Metab Brain Dis       Date:  2006-07-25       Impact factor: 3.584

Review 6.  Current concepts in normal and defective angiogenesis: implications for systemic sclerosis.

Authors:  Mary Jo Mulligan-Kehoe; Michael Simons
Journal:  Curr Rheumatol Rep       Date:  2007-05       Impact factor: 4.592

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.